166 related articles for article (PubMed ID: 1277169)
1. Prophylaxis of early preneoplastic lesions of the mammary gland.
Welsch CW
Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
[TBL] [Abstract][Full Text] [Related]
2. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Welsch CW
J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and the development and progression of early neoplastic mammary gland lesions.
Welsch CW
Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
Welsch CW; Lambrecht LK; Hassett CC
J Natl Cancer Inst; 1977 Apr; 58(4):1135-8. PubMed ID: 576623
[TBL] [Abstract][Full Text] [Related]
5. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
Yanai R; Nagasawa H
J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
[No Abstract] [Full Text] [Related]
6. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of spontaneously developing mammary carcinoma in C3H-HeJ female mice by suppression of prolactin.
Welsch CW; Gribler C
Cancer Res; 1973 Nov; 33(11):2939-46. PubMed ID: 4795906
[No Abstract] [Full Text] [Related]
8. Inhibition of mammary tumorigenesis in carcinogen-treated Lewis rats by suppression of prolactin secretion.
Welsch CW; Brown CK; Goodrich-Smith M; Van J; Denenberg B; Anderson TM; Brooks CL
J Natl Cancer Inst; 1979 Nov; 63(5):1211-4. PubMed ID: 116049
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
[TBL] [Abstract][Full Text] [Related]
10. 17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.
Welsch CW; Adams C; Lambrecht LK; Hassett CC; Brooks CL
Br J Cancer; 1977 Mar; 35(3):322-8. PubMed ID: 576837
[TBL] [Abstract][Full Text] [Related]
11. Suppression by kampo medicines in preneoplastic mammary hyperplastic alveolar nodules of SHN virgin mice.
Sakamoto S; Muroi N; Matsuda M; Tajima M; Kudo H; Kasahara N; Suzuki S; Sugiura Y; Kuwa K; Namiki H
Planta Med; 1993 Oct; 59(5):425-7. PubMed ID: 8255936
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of spontaneous mammary tumorigenesis by temporal inhibition of prolactin secretion in rats at young ages.
Nagasawa H; Morii S
Cancer Res; 1981 May; 41(5):1935-7. PubMed ID: 7214361
[TBL] [Abstract][Full Text] [Related]
13. Long-term cyclophosphamide treatments against primary mammary tumors in C3H/He mice.
Costanza ME; Vaage J
J Natl Cancer Inst; 1983 Mar; 70(3):511-6. PubMed ID: 6572739
[TBL] [Abstract][Full Text] [Related]
14. 6-Methyl-8-beta-ergoline-acetonitrile (MEA)-induced suppression of mammary tumorigenesis in C3H/HeJ female mice.
Welsch CW; Gribler C; Clemens JA
Eur J Cancer (1965); 1974 Sep; 10(9):595-600. PubMed ID: 4477735
[No Abstract] [Full Text] [Related]
15. Effect of ovariectomy at different ages on development of mammary tumors in (C3H x R3)F1 mice.
Richardson FL
J Natl Cancer Inst; 1967 Aug; 39(2):347-54. PubMed ID: 18623949
[TBL] [Abstract][Full Text] [Related]
16. Changes in uterine morphology which accompany the development of preneoplastic and neoplastic mammary lesions in old mice.
Brophy MO; Spring-Mills EJ
Scan Electron Microsc; 1984; (Pt 1):335-42. PubMed ID: 6740234
[TBL] [Abstract][Full Text] [Related]
17. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
18. Calories, parity, and prolactin influence mammary epithelial kinetics and differentiation and alter mouse mammary tumor risk.
Engelman RW; Day NK; Good RA
Cancer Res; 1993 Mar; 53(5):1188-94. PubMed ID: 8382558
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of prenatal and neonatal administration of 5beta-dihydrotestosterone on normal and neoplastic mammary development in mice.
Yanai R; Mori T; Nagasawa H
Cancer Res; 1977 Dec; 37(12):4456-9. PubMed ID: 200350
[TBL] [Abstract][Full Text] [Related]
20. Effect of tamoxifen on mammary preneoplasia: relevance to chemopreventive intervention.
Telang NT; Bradlow HL; Osborne MP
Cancer Detect Prev; 1994; 18(4):313-21. PubMed ID: 7982241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
